Abpro Hldgs

Biotechnology
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

$11.9M

Market Cap • 5/22/2025

2023

(2 years)

Founded

2024

(1 year ago)

IPO

NASDAQ

Listing Exchange

Flag of US

Woburn

Headquarters • Massachusetts